UY36742A - METHODS FOR THE TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) WITH BUPROPION AND TRAZODONE COMBINATION TREATMENT - Google Patents

METHODS FOR THE TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) WITH BUPROPION AND TRAZODONE COMBINATION TREATMENT

Info

Publication number
UY36742A
UY36742A UY0001036742A UY36742A UY36742A UY 36742 A UY36742 A UY 36742A UY 0001036742 A UY0001036742 A UY 0001036742A UY 36742 A UY36742 A UY 36742A UY 36742 A UY36742 A UY 36742A
Authority
UY
Uruguay
Prior art keywords
treatment
hsdd
trazodone
bupropion
methods
Prior art date
Application number
UY0001036742A
Other languages
Spanish (es)
Inventor
Clayton Anita
Derogatis Leonard
Katz Molly
Meston Cindy
Robert E Pyke
Robert Taylor Segraves
Nick G Sitchon
Original Assignee
S1 Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57758862&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY36742(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S1 Biopharma Inc filed Critical S1 Biopharma Inc
Publication of UY36742A publication Critical patent/UY36742A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a métodos de tratamiento de mujeres para el Trastorno del Deseo Sexual Hipoactivo (HSDD) con tratamientos diarios orales de combinaciones de bajas dosis y altas dosis de trazodona y bupropión.The present invention relates to methods of treating women for Hypoactive Sexual Desire Disorder (HSDD) with daily oral treatments of combinations of low doses and high doses of trazodone and bupropion.

UY0001036742A 2016-06-17 2016-06-20 METHODS FOR THE TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) WITH BUPROPION AND TRAZODONE COMBINATION TREATMENT UY36742A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662351904P 2016-06-17 2016-06-17

Publications (1)

Publication Number Publication Date
UY36742A true UY36742A (en) 2016-12-30

Family

ID=57758862

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036742A UY36742A (en) 2016-06-17 2016-06-20 METHODS FOR THE TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) WITH BUPROPION AND TRAZODONE COMBINATION TREATMENT

Country Status (9)

Country Link
KR (1) KR20170142797A (en)
AR (2) AR105047A1 (en)
AU (1) AU2016204151A1 (en)
CA (1) CA2933921A1 (en)
CL (1) CL2016001597A1 (en)
MX (1) MX2016008272A (en)
PE (1) PE20180023A1 (en)
UY (1) UY36742A (en)
WO (1) WO2017218018A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897864A (en) * 1996-05-23 1999-04-27 Cohen; Alan J. Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba
HUP0202719A3 (en) * 2001-08-21 2006-01-30 Pfizer Prod Inc Pharmaceutical compositions for the treatment of female sexual dysfunctions
KR20070014184A (en) * 2004-04-22 2007-01-31 베링거 인겔하임 인터내셔날 게엠베하 New pharmaceutical compositions for the treatment of sexual disorders ii
EP1998773A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware New therapeutic combinations for the treatment of depression
CA2881388A1 (en) * 2012-08-06 2014-02-13 S1 Pharmaceuticals, Inc. Treatment regimens

Also Published As

Publication number Publication date
AR105047A1 (en) 2017-08-30
CL2016001597A1 (en) 2017-10-06
KR20170142797A (en) 2017-12-28
AU2016204151A1 (en) 2018-01-18
MX2016008272A (en) 2017-12-18
PE20180023A1 (en) 2018-01-09
AR105087A1 (en) 2017-09-06
CA2933921A1 (en) 2017-12-17
WO2017218018A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
CL2018001152A1 (en) Compositions and methods for cancer treatment
CO2019008783A2 (en) Cyclic dinucleotide compounds for the treatment of cancer
CO2020010956A2 (en) Compositions and methods for the treatment of cancer and immune disorders using veillonella bacteria
AR113881A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISORDERS USING THE BLAUTIA STRAIN
DOP2017000025A (en) COMPOSITIONS AND METHODS OF USE TO TREAT METABOLIC DISORDERS
GT201700072A (en) COMPOSITIONS AND METHODS OF USE TO TREAT METABOLIC DISORDERS
PH12017500746B1 (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
UY36550A (en) OLIGÓMEROS ANTISENTIDO DE TAU AND ITS USES
ES2765949T8 (en) Therapy involving antibodies to claudin 18.2 for cancer treatment
EA201790737A1 (en) COMBINED THERAPY
CL2018000914A1 (en) Compuestos derivados del acido (s)-3-amino-4-ciclopent-1-en-1-carboxilico, inactivadores de gaba aminotransferasa; composicion farmaceutica; metodo de tratamiento de trastornos psicologicos, neurologicos, adicciones, carcinoma hepatocelular, entre otras.
CR20160308A (en) COMBINATIONS OF INHIBITORS OF HISTONA DEACETILASE AND IMMUNOMODULATING PHARMACOS
CO2019007205A2 (en) Therapeutic uses of an insect powder
PH12017500637A1 (en) Inhibitors of lysine gingipain
JOP20190241B1 (en) Epinephrine spray formulations
CL2021001256A1 (en) Vaccination with the alpha 3 domain of mica/b for the treatment of cancer (divisional sol 201801470)
MX2017010654A (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders.
CR20150640S (en) APPARATUS TO HAIR HAIR
UY36742A (en) METHODS FOR THE TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) WITH BUPROPION AND TRAZODONE COMBINATION TREATMENT
EA201790220A1 (en) TREATMENT OF SYMPTOMS ASSOCIATED WITH ANDROGEN-DEPRIVATION THERAPY
RU2014154366A (en) APPLICATION OF THE PROBIOTIC STRAIN OF THE MICROOORGANISM ENTEROCOCCUS FAECIUM L3 FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CL2018002930A1 (en) (+) - azasetron for use in the treatment of ear disorders.
AR092169A1 (en) PHARMACEUTICAL SYNERGIC COMPOSITION ADAPTED TO BE ADMINISTRABLE ORALALLY AS AN ANTIPARASITARY AND PROCESSES TO PREPARE IT
NZ725354A (en) Transdermal formulations of pergolide and uses thereof
CY1124597T1 (en) GYNURA PROCUMBENS OIL EXTRACT FOR THE TREATMENT OF VARIOUS DERMATOLOGICAL DISEASES AND ITS PREPARATION PROCESS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20221129